ArticleWorld journal of surgical oncology2026
Integrated transcriptomic and metabolomic analyses reveal targeting hexokinase 2 disrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth.
Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.